{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:56:42Z","timestamp":1789750602877,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urolonc.2026.110999","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:28:23Z","timestamp":1770712103000},"page":"110999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Estimating the prevalence of germline mutations in DNA mismatch repair genes among patients with upper tract urothelial carcinoma: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"44","author":[{"given":"Joseph","family":"Moryousef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-0818","authenticated-orcid":false,"given":"Piotr","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.110999_bib0001","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.110999_bib0002","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025. [cited 2025 May 10]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"10.1016\/j.urolonc.2026.110999_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1097-0215(19960220)69:1<38::AID-IJC9>3.0.CO;2-X","article-title":"Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome)","volume":"69","author":"Lynch","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2026.110999_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ng.283","article-title":"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2032 exons of TACSTD1","volume":"41","author":"Ligtenberg","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2026.110999_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6,350 carriers of pathogenic mismatch repair variants: findings from the prospective Lynch syndrome database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10689-007-9164-6","article-title":"Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)","volume":"7","author":"Geary","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.urolonc.2026.110999_bib0007","first-page":"1","article-title":"Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis","volume":"3","author":"Chandran","year":"2024","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.urology.2022.02.006","article-title":"Immunohistochemical screening of upper tract urothelial carcinomas for Lynch syndrome diagnostics: a systematic review","volume":"165","author":"Rasmussen","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2026.110999_bib0009","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.urolonc.2026.110999_bib0010","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0011","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2026.110999_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1464-410X.2005.05585.x","article-title":"Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma","volume":"96","author":"Roupret","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.110999_bib0013","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for Lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jjco\/hyz140","article-title":"Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population","volume":"50","author":"Ito","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.19.01395","article-title":"Cancer susceptibility mutations in patients with urothelial malignancies","volume":"38","author":"Carlo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0016","first-page":"1","article-title":"Genomic profiling of Chinese patients with urothelial carcinoma","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2026.110999_bib0017","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2026.110999_bib0018","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jjco\/hyac141","article-title":"Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese","volume":"52","author":"Sekine","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0019","first-page":"1","article-title":"Inherited mutations in Chinese patients with upper tract urothelial carcinoma","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0020","first-page":"1","article-title":"Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy and immunotherapy","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0021","doi-asserted-by":"crossref","first-page":"15304","DOI":"10.1002\/cam4.6175","article-title":"Mutational pattern of homologous recombination repair (HRR)-related genes in upper tract urothelial carcinoma","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0022","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00428-023-03626-2","article-title":"Lynch syndrome-associated upper tract urothelial carcinoma frequently occurs in patients older than 60 years: an opportunity to revisit urology clinical guidelines","volume":"483","author":"Pivovarcikova","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2026.110999_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1269097","article-title":"Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1\/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0024","first-page":"1","article-title":"Detection of urothelial carcinoma in Lynch syndrome using a novel microsatellite instability assay on postal urine samples","author":"Hall","year":"2025","journal-title":"SSRN"},{"key":"10.1016\/j.urolonc.2026.110999_bib0025","first-page":"1","article-title":"Comprehensive comparison of somatic, germline, and immune cell profiles in upper tract and bladder urothelial carcinoma","volume":"9","author":"Yuen","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.774202","article-title":"Identification of germline mutations in upper tract urothelial carcinoma with suspected Lynch syndrome","volume":"12","author":"Guan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2003.017871","article-title":"Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma","volume":"41","author":"Roupret","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.urolonc.2026.110999_bib0028","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10147-024-02518-y","article-title":"Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome","volume":"29","author":"Ito","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0029","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2026.110999_bib0030","first-page":"1","article-title":"Genomic landscape and clinical relevance in Chinese patients with upper tract urothelial carcinoma","volume":"9","author":"Shang","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0031","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2026.110999_bib0032","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.34.1.359","article-title":"DNA mismatch repair and genetic instability","volume":"34","author":"Harfe","year":"2000","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.urolonc.2026.110999_bib0033","first-page":"5059","article-title":"Microsatellite instability: marker of a mutator phenotype in cancer","volume":"54","author":"Loeb","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2026.110999_bib0034","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2022.10.024","article-title":"Molecular testing for endometrial cancer: an SGO clinical practice statement","volume":"168","author":"Walsh","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0036","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.gim.2022.01.014","article-title":"Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: systematic review and meta-analysis","volume":"24","author":"Abu-Ghazaleh","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0037","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","article-title":"The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis","volume":"21","author":"Ryan","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0038","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cge.12559","article-title":"Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey","volume":"87","author":"Barrow","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.urolonc.2026.110999_bib0039","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00143","article-title":"Genomic characterization of upper tract urothelial carcinoma in patients with Lynch syndrome","volume":"2","author":"Donahue","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0041","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the Prospective Lynch Syndrome Database","volume":"66","author":"Moller","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2026.110999_bib0042","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","article-title":"Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Hodan","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2026.110999_bib0043","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupret","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1147591","article-title":"Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors","volume":"13","author":"Rasmussen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2020.07.001","article-title":"Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome","volume":"103","author":"Chen","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0046","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/path.4419","article-title":"Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers","volume":"234","author":"Geurts-Giele","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2026.110999_bib0047","first-page":"808","article-title":"Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines","volume":"57","author":"Kane","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2026.110999_bib0048","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2026.110999_bib0049","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:52:23Z","timestamp":1784548343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078143926000098"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110999","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the prevalence of germline mutations in DNA mismatch repair genes among patients with upper tract urothelial carcinoma: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110999"}}